Ex parte GROSS - Page 1




                    THIS OPINION WAS NOT WRITTEN FOR PUBLICATION                      

          The opinion in support of the decision being entered today (1) was not written
          for publication in a law journal and (2) is not binding precedent of the Board.

                                                               Paper No. 48           
                      UNITED STATES PATENT AND TRADEMARK OFFICE                       
                                    ____________                                      
                         BEFORE THE BOARD OF PATENT APPEALS                           
                                  AND INTERFERENCES                                   
                                    ____________                                      
                              Ex parte STEVEN S. GROSS                                
                                    ____________                                      
                                Appeal No. 1996-3326                                  
                             Application No. 08/063,067                               
                                    ____________                                      
                               HEARD:  April 19, 2000                                 
                                    ____________                                      
          Before KIMLIN, WALTZ, and KRATZ, Administrative Patent Judges.              
          WALTZ, Administrative Patent Judge.                                         




          DECISION ON APPEAL                                                          
               This is an appeal under 35 U.S.C. § 134 from the                       
          examiner’s final rejection of claims 1 through 12, which are                
          the only claims in this application.                                        
               According to appellant, the invention is directed to two               
          embodiments.  The first embodiment involves the administration              
          of known groups of tetrahydrobiopterin synthesis antagonists                






Page:  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007